Danaher Corp (DHR) (Q3 2026) Earnings Call Highlights: Core Growth Accelerates to 5.5% Ex-Respiratory as EPS Guidance Rises
· gurufocus.com
Revenue: Q3 2026 sales of $6.6 billion.Core Revenue Growth: Up 3% overall; up 5.5% excluding respiratory revenue (100 bps acceleration from Q2).Respiratory Reve
Revenue: Q3 2026 sales of $6.6 billion.
Q3 2026 sales of $6.6 billion. Core Revenue Growth: Up 3% overall; up 5.5% excluding respiratory revenue (100 bps accel...